Castor oil and mineral oil nanoemulsion: Development and compatibility with a soft contact lens

Pharmaceutical Development and Technology

Volumn 19, Issue 2, 2014, Pages 232-237

  Katzer, Tatiele ^a   Chaves, Paula ^a   Bernardi, Andressa ^a   Pohlmann, Adriana R ^a   Guterres, Silvia S ^a   Beck, Ruy C R ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Castor oil; Contact lens; Mineral oil; Nanoemulsion; Ocular delivery

Indexed keywords

CASTOR OIL; MINERAL OIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORNEA CELL; DISPERSION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; EYE IRRITATION; ION PERMEABILITY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOFT CONTACT LENS; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY; ZETA POTENTIAL;

ANIMALS; CASTOR OIL; CELL LINE; CELL SURVIVAL; CHICKENS; CONTACT LENSES, HYDROPHILIC; EMULSIONS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MINERAL OIL; OPHTHALMIC SOLUTIONS; PARTICLE SIZE; PERMEABILITY; RABBITS;

EID: 84899800602     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2013.769569     Document Type: Article

References (27)

1. Alvarez LC, Hiratani H, Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am J Drug Deliv 2006;4:131-51.
2. Pritchard N, Fonn D, Brazeau D. Discontinuation of contact lens wear: a survey. Int Contact Lens Clin 1999;26:157-62.
3. Ruben M, Brown N, Lobascher D, et al. Clinical manifestations secondary to soft contact lens wear. Br J Ophthalmol 1976;60:529-31.
4. Smith A. Giant papillary conjunctivitis. J Am Optom Assoc 1990;61:42-6.
5. Lozato PA, Pisella PJ, Baudouin C. The lipid layer of the lacrimal tear film: physiology and pathology. J Fr Ophthalmol 2001;24:643-58.
6. Suchecki JK, Donshik P, Ehlers WH. Contact lens complications. Ophthalmol Clin North Am 2003;16:471-84.
7. Maïssa C, Guillon M, Simmons P, Vehige J. Effect of castor oil emulsion eyedrops on tear film composition and stability. Cont Lens Anterior Eye 2010;33:76-82.
8. Mishima S, Mauricie DM. The oily layer of the tear film and evaporation from the corneal surface. Exp Eye Res 1961;1:39-45.
9. Sheng JJ. Mineral oil. In: Rowe RC, Sheskey PJ, Quinn ME, eds. Handbook of pharmaceutical excipients. Washington, DC: American Pharmacists Association; 2009:445-7.
10. Vieira C, Evangelista S, Cirillo R, et al. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation. Mediators Inflamm 2009;9:223-8.
11. Peng CC, Ben-Shlomo A, Mackay EO, et al. Drug delivery by contact lens in spontaneously glaucomatous dogs. Curr Eye Res 2012;37:204-11.
12. Xu J, Li X, Sun F. Cyclodextrin-containing hydrogels for contact lens as a platform for drug incorporation and release. Acta Biomater 2010;6:486-93.
13. Lee TW-Y, Robinson JR. Ocular penetration enhancers. In: Mitra AK, ed. Ophthalmic drug delivery systems. New York (NY): Marcel Dekker; 2003:281-308.
14. Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog Retin Eye Res 2002;21:15-35.
15. Efron N. Obituary-rigid contact lenses. Cont Lens Anterior Eye 2010;33:245-52.
16. Bouchemal K, Briançon S, Perrier E, Fessi H. Nanoemulsion formation using spontaneous emulsification: solvent, oil and surfactant optimization. Int J Pharm 2004;280:241-51.
17. Luepke NP. Hen's eggs chorioallantoic membrane test for irritation potential. Food Chem Toxicol 1985;23:287-91.
18. Spielmann H, Kalweit S, Liebsch M, et al. Validation study of alternatives to the Draize eye irritation test in Germany: cytotoxicity testing and HET-CAM test with 136 industrial chemicals. Toxicol In Vitro 1993;4:505-10.
19. Jain MR. Drug delivery through soft contact lenses. Br J Ophthalmol 1988;72:150-4.
20. Domschke A, Lohmann D, Winterton L. On-eye mobility of soft oxygen permeable contact lenses. Proceedings of the ACS Spring National Meeting. Polymeric Materials Science and Engineering Proceedings; 1997; San Francisco.
21. Nicolson P, Baron RC, Chabrecek P, et al. Extended wear ophthalmic lens. United States Patent 5760100; 1998.
22. Kim J, ConwayA, Chauhan A. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses. J Biomater 2008;29:2259-69.
23. Alves MP, Scarrone AL, Santos M, et al. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007;341:215-20.
24. Fontana MC, Coradini K, Guterres SS. Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system. J Biomed Nanotechnol 2009;5:1-10.
25. Hussein OA, Salama HA, Ghorab M. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech 2009;10:808-19.
26. Kishore AS, Surekha PA, Sekhar PVR, et al. Hen egg chorioallantoic membrane bioassay: an in vitro alternative to Draize eye irritation test for pesticide screening. Int J Toxicol 2008;27:449-53.
27. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001;Appendiz 3:appendiz 3b.